207_Combined course Presentations

HD0607 FFS in PET2 NEG +/- Radiotherapy (N=195) (interim analysis, presented at Lugano ICML 2015)

1,00

94%

90%

85%

0,75

0,50

P

HR* (95% CI)

Consolidative RT

1.00 0.38 (0.14-1.05)

TOT 32/97 (33.0%) NO RXT 4/98 (14.3%) RXT 5/97 (5.2%) All patients (195)

0.063

0,25

NO RT

Log Rank Test P = 0.053

0,00

1

2

5

4

0

3

Gallamini et al, ICML (Lugano) 2015, abstract 118